BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  These 2 Biotechs Just Won Bristol-Myers’ Golden Ticket Award

  The company announced that Neutrolis and Remora Therapeutics are the winners of Bristol-Myers Squibb’s 2017 Golden Tickets for LabCentral.

  November 28, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Auris Shifts Plans for Hearing-Loss Drug After Phase III Flop

  AM-111 failed to meet its primary endpoint, although the company is putting a positive spin on it by noting it was effective in a subpopulation.

  November 28, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Genetown

  Why the Best is Yet to Come for This Tiny Massachusetts Biotech

  On Oct. 6, the FDA approved Flexion Therapeutics’ Zilretta for osteoarthritis knee pain and is now in the middle of launching the drug and installing its commercial operations.

  November 28, 2017

   · 

  3 min read

   · 

  Mark Terry
• Business

  Aspen Pharma of South Africa to Expand in China via Partnerships

  Aspen Pharmacare Holdings, a South African generic drug company, plans to establish partnerships to build its China drug portfolio, according to management.

  November 28, 2017

   · 

  1 min read
• 

  Job Trends

  Clovis Expands Bay Area Footprint With Huge Lease in Oakland

  Clovis Oncology has solidified its physical footprint in the Bay Area with a 32,000 square foot space it secured for 10 years through property developer TMG Partners.

  November 28, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Job Trends

  Bay Area’s Gritstone Oncology to Ramp Up Hiring at New Manufacturing Facility

  Gritstone Oncology is hanging a “help wanted” sign as the company looks to staff a new 43,000 square-foot manufacturing facility in Pleasanton, Calif. that will be the center of the company’s immunotherapy manufacturing efforts.

  November 28, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Johnson & Johnson Yanks Plans for First R&D Facility in the UK

  J&J is balking at a plan to build a site in Britain due to concerns over the economy.

  November 28, 2017

   · 

  2 min read

   · 

  Alex Keown
• Deals

  Why a Buyout Deal May Not Be in the Cards for Acadia

  A look at why a potential buyout of Acadia might not be as likely as some have suggested.

  November 28, 2017

   · 

  1 min read
• 

  Business

  ITUS Pushes CAR-T Program for Solid Tumors, Develops Early Cancer Detection Platform

  Tiny ITUS believes it is on track to develop a CAR-T treatment for solid tumors.

  November 28, 2017

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Bayer Pharma Head Denies Pipeline Problem

  With the $63.5B takeover of Monsanto by Bayer taking longer than expected, and a key patent for Xarelto expiring in 2024, Bayer’s execs are finding themselves defending their decisions.

  November 28, 2017

   · 

  3 min read

   · 

  Mark Terry